Back to results
US 2017/0224809 A1Published application
Use of superantigens for improving mucosal allergen specific immunotherapy in non-human mammals
AssigneePremune AB
InventorsSofia Östman, Agnes Wold
Life of this patent
Estimating the term…
Abstract
Use of a superantigen in mucosal allergen specific immune therapy (ASIT) in a non-human mammal to enhance the effect thereof. In order to enhance the effect of the mucosal ASIT, the superantigen is mucosally administered before, or with, the allergen to the non-human mammal.
Claims25
A method of enhancing the effect of allergen specific immune therapy (ASIT) in a non-human mammal suffering from hypersensitivity towards an allergen, the method comprising the steps of:
- administering the allergen to the non-human mammal;
- and
- administering a superantigen before, or with, the allergen to the non-human mammal in need thereof.
(canceled)
A composition comprising a superantigen, an allergen and at least one pharmaceutical acceptable carrier or excipient.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.